EXPD vs IRD · P/E 26, rev $10.60B vs rev $11.0M
Expeditors International of Washington, Inc. (EXPD) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. IRD currently screens at market cap $35.7M.
Not investment advice. Open the EXPD and IRD stock pages for the full models.
Not investment advice.